Kümpfel T - Search Results

1

Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F; German Network for Research on Autoimmune Encephalitis (GENERATE). Mueller SH, et al. Among authors: kumpfel t. Ann Neurol. 2018 Apr;83(4):863-869. doi: 10.1002/ana.25216. Ann Neurol. 2018. PMID: 29572931

2

Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume.

Schumann EM, Kümpfel T, Then Bergh F, Trenkwalder C, Holsboer F, Auer DP. Schumann EM, et al. Among authors: kumpfel t. Ann Neurol. 2002 Jun;51(6):763-7. doi: 10.1002/ana.10187. Ann Neurol. 2002. PMID: 12112083

3

Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.

Krumbholz M, Pellkofer H, Gold R, Hoffmann LA, Hohlfeld R, Kümpfel T. Krumbholz M, et al. Among authors: kumpfel t. Arch Neurol. 2007 Sep;64(9):1331-3. doi: 10.1001/archneur.64.9.1331. Arch Neurol. 2007. PMID: 17846274

4

[Progress of therapy in patients with multiple sclerosis].

Kümpfel T, Havla J, Hohlfeld R. Kümpfel T, et al. MMW Fortschr Med. 2010 Mar 4;152(9):42-4. MMW Fortschr Med. 2010. PMID: 20384096 German. No abstract available.

5

De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate.

Havla J, Gerdes LA, Meinl I, Krumbholz M, Faber H, Weber F, Pellkofer HL, Hohlfeld R, Kümpfel T. Havla J, et al. Among authors: kumpfel t. J Neurol. 2011 Sep;258(9):1665-9. doi: 10.1007/s00415-011-5996-y. Epub 2011 Mar 23. J Neurol. 2011. PMID: 21431380

6

Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sample.

Lill CM, Schjeide BM, Akkad DA, Blaschke P, Winkelmann A, Gerdes LA, Hoffjan S, Luessi F, Dörner T, Li SC, Steinhagen-Thiessen E, Lindenberger U, Chan A, Hartung HP, Aktas O, Lohse P, Kümpfel T, Kubisch C, Epplen JT, Zettl UK, Bertram L, Zipp F. Lill CM, et al. Among authors: kumpfel t. Neurogenetics. 2012 Feb;13(1):83-6. doi: 10.1007/s10048-011-0305-6. Epub 2011 Nov 18. Neurogenetics. 2012. PMID: 22095036

7

Failure of natalizumab to prevent relapses in neuromyelitis optica.

Kleiter I, Hellwig K, Berthele A, Kümpfel T, Linker RA, Hartung HP, Paul F, Aktas O; Neuromyelitis Optica Study Group. Kleiter I, et al. Among authors: kumpfel t. Arch Neurol. 2012 Feb;69(2):239-45. doi: 10.1001/archneurol.2011.216. Arch Neurol. 2012. PMID: 22332191

8

Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.

Havla JB, Pellkofer HL, Meinl I, Gerdes LA, Hohlfeld R, Kümpfel T. Havla JB, et al. Among authors: kumpfel t. Arch Neurol. 2012 Feb;69(2):262-4. doi: 10.1001/archneurol.2011.1057. Arch Neurol. 2012. PMID: 22332194

9

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.

Havla J, Tackenberg B, Hellwig K, Meinl I, Krumbholz M, Seitz F, Eienbröker C, Gold R, Hohlfeld R, Kleiter I, Kümpfel T. Havla J, et al. Among authors: kumpfel t. J Neurol. 2013 May;260(5):1382-7. doi: 10.1007/s00415-012-6808-8. Epub 2012 Dec 25. J Neurol. 2013. PMID: 23266894

10

Havla J, Lohse P, Gerdes LA, Hohlfeld R, Kümpfel T. Havla J, et al. Among authors: kumpfel t. J Rheumatol. 2013 Mar;40(3):261-4. doi: 10.3899/jrheum.120729. Epub 2013 Jan 15. J Rheumatol. 2013. PMID: 23322460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page